The treatment of Angina & Meniere's Disease with vitamins

Angina and Meniere's Disease: Mitamins custom make quality formulas for the treatment of Angina & Meniere's Disease with vitamins. A Angina & Meniere's Disease formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Angina and Meniere's Disease

  • Amount Per Serving
    % DV
    Vitamin C
    200
    mg
    333%
    Vitamin E
    200
    IU
    667%
    Niacin
    50
    mg
    250%
    Vitamin B6
    50
    mg
    2500%
    Magnesium
    100
    mg
    25%
    CoQ-10
    50
    mg
    *
    Flax Seed Powder
    50
    mg
    *
  • Amount Per Serving
    % DV
    Lecithin
    50
    mg
    *
    Hawthorn Extract
    250
    mg
    *
    L-Arginine
    250
    mg
    *
    L-Carnitine
    250
    mg
    *
    Taurine
    250
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Angina and Meniere's Disease
Monthly Cost: $36.31
Serving Size:4-5
30 Days Money Back Guarantee
100% Satisfaction Guarantee

Angina and Meniere's Disease Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
Update This Formula
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Michael J. Fox Foundation And New York Academy Of Sciences To Host First Major Parkinson's Drug Development Conference
The Michael J. Fox Foundation for Parkinson's Research (MJFF) and The New York Academy of Sciences will co-host the inaugural PD Therapeutics Conference on Thursday, October 25, in New York City. This meeting is the first and only major scientific symposium exclusively focused on the development of innovative drugs to target Parkinson's disease.
Clinical Trials Of SNS-595 And SNS-314 For Patients With Relapsed And Refractory Acute Leukemias
Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) announced that patient dosing has commenced in clinical trials to evaluate two of the company's anti-cancer product candidates, SNS-595 and SNS-314. Sunesis' lead product candidate, SNS-595, is being evaluated in combination with cytarabine in a Phase 1b clinical trial of patients with relapsed and/or refractory acute leukemias.
This information concerning the support of Angina and Meniere's Disease treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Mitamins Logo
Home  Multi-Conditions formulas  Heart & Vascular Health  Angina  Angina and Meniere's Disease
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments